http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014154396-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B32-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 |
| filingDate | 2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014154396-A |
| titleOfInvention | LIQUID MEDICINAL CONTAINING CARBON OXIDE DISSOLVED IN IT AND THE THERAPEUTIC METHOD OF USE |
| abstract | 1. A liquid drug containing a liquid with dissolved oxygen dioxide, which is introduced using a device for injecting liquid. The liquid medicine according to claim 1, wherein the fluid injection device is an injection administered with pressure to obtain a rate of administration of 0.1 ml / min or more with respect to blood pressure when said fluid is injected into the artery. The liquid medicament according to claim 1 or 2, wherein the fluid injection device is an injection administered by syringe or pump. A liquid drug according to claim 1 or 2, wherein the liquid with carbon dioxide dissolved in it is a physiological solution. A liquid drug according to claim 1 or 2, wherein the liquid with the carbon dioxide dissolved in it is blood compatible with the blood group of the patient. A liquid drug according to claim 1 or 2, wherein the liquid with carbon dioxide dissolved in it is a fat emulsion. A liquid drug according to claim 1 or 2, aimed at a tumor. A liquid medicine according to claim 7, which is used in combination with one or two or more types of therapy selected from surgical treatment, chemotherapy, radiotherapy and immunotherapy of tumors. A liquid drug according to claim 1 or 2, aimed at an autoimmune disease. 10. The liquid drug of claim 9, which is used in combination with one or two or more of non-steroidal anti-inflammatory agents, steroidal anti-inflammatory agents, an immunosuppressant, and exchange transfusion for the treatment of an autoimmune disease. |
| priorityDate | 2012-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.